These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1004 related articles for article (PubMed ID: 26851040)

  • 41. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
    Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
    Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
    Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
    Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade.
    Kademani D; Bell RB; Bagheri S; Holmgren E; Dierks E; Potter B; Homer L
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1599-605. PubMed ID: 16243176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection.
    Prabhu RS; Hanasoge S; Magliocca KR; Moeller BJ; Milas ZL; Hall WA; El-Deiry M; Wadsworth JT; Higgins KA; Beitler JJ
    Cancer; 2014 May; 120(10):1499-506. PubMed ID: 24510454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant treatment for post-operative head and neck squamous cell carcinoma.
    Kiyota N; Tahara M; Fujii M
    Jpn J Clin Oncol; 2015 Jan; 45(1):2-6. PubMed ID: 25411434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy.
    Prabhu RS; Hanasoge S; Magliocca KR; Hall WA; Chen SA; Higgins KA; Saba NF; El-Deiry M; Grist W; Wadsworth JT; Chen AY; Beitler JJ
    Head Neck; 2015 Jun; 37(6):777-82. PubMed ID: 24596123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis.
    Fakhrian K; Thamm R; Knapp S; Molls M; Pigorsch S; Haller B; Geinitz H
    Strahlenther Onkol; 2012 Jan; 188(1):56-61. PubMed ID: 22189437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of cysteine-glutamate transporter and CD44 for prediction of recurrence and survival in patients with oral cavity squamous cell carcinoma.
    Lee JR; Roh JL; Lee SM; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY
    Head Neck; 2018 Nov; 40(11):2340-2346. PubMed ID: 30303590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
    Amoils M; Lee CS; Sunwoo J; Aasi SZ; Hara W; Kim J; Sirjani D; Colevas AD; Chang AL; Divi V
    Head Neck; 2017 May; 39(5):881-885. PubMed ID: 28252823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer.
    Iype EM; Sebastian P; Mathew A; Balagopal PG; Varghese BT; Thomas S
    Oral Oncol; 2008 Dec; 44(12):1134-8. PubMed ID: 18486527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perineural invasion: Independent prognostic factor in oral cancer that warrants adjuvant treatment.
    Nair D; Mair M; Singhvi H; Mishra A; Nair S; Agrawal J; Chaturvedi P
    Head Neck; 2018 Aug; 40(8):1780-1787. PubMed ID: 29707840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nodal factors predictive of recurrence and survival in patients with oral cavity squamous cell carcinoma.
    Son HJ; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
    Clin Otolaryngol; 2018 Apr; 43(2):470-476. PubMed ID: 28981214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.
    Jang WI; Wu HG; Park CI; Kim KH; Sung MW; Kim MJ; Choung PH; Lee JH; Choi JY
    Jpn J Clin Oncol; 2008 Jun; 38(6):395-401. PubMed ID: 18573849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
    Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
    Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
    Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
    BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postoperative radiotherapy is dispensable for OSCC patients with micrometastases in lymph nodes.
    Pu YM; Yang Y; Wang YJ; Ding L; Huang XF; Wang ZY; Ni YH; Hu QG
    Virchows Arch; 2018 May; 472(5):797-805. PubMed ID: 29629513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evolution of treatment and high-risk features in resectable locally advanced Head and Neck squamous cell carcinoma with special reference to extracapsular extension of nodal disease.
    Krstevska V
    J BUON; 2015; 20(4):943-53. PubMed ID: 26416042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.